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ABSTRACT 
 
      Sensitivity testing for pathogenic bacteria isolated is usually 
conducted by the disc-diffusion method. Such a method gives a clue 
about the drug of choice; however, the technique will not give an 
indicator about the concentrations of the antibiotics. The use of 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
manual Hi-comb technique will give a clear an indicator about the 
minimum inhibitory concentration of antibiotics chosen .The Gram-
positive bacterial isolates , were Staphylococcus aureus and 
Staphylococcus epidermidis, which were provided by human 
laboratories as well as Gram-negative isolates which were Escherichia 
coli, Pseudomonas aeruginosa, klebsiella pneumoniae, which were 
provide by veterinary laboratories Salmonella typhimurium and 
Salmonella para typhimurium; were provided by human laboratories. 
Type cultures Staph aureus ATCC 25932, E.coli ATCC 25922 and 
Pseudomonas aeruginosa ATCC 27873 were used as control for 
comparison. The control strains were provided by the Central Public 
Health Laboratory Khartoum.  All bacteria were tested against ten 
antibiotics viz: Ciprofloxacin, norfloxacin, azithromycin, ampicillin, 
cloxacillin, amoxicillin cefaclor, tetracycline, doxycycline and 
erythromycin. Sixty six point seven per cent of the animals sources 
were sensitive while 33.3% were resistant and eighty five per cent of 
human sources were sensitive while 15% were resistant.  The range of 
sensitivity of the tested bacterial strains against the various antibiotics 
were as follows: Ciprofloxacin 0.0078-0.0156µg/ml, norfloxacin 
V 
0.032-0.5µg/ml, azithromycin0.125-1µg/ml, ampicillin 0.0156- 
2µg/ml, cloxacillin 0.063-4µg/ml, amoxicillin 4-8µg/ml, cefaclor 
0.063-2µg/ml, tetracycline 0.032-4 µg/ml, doxycycline 0.063-8µg/ml 
and erythromycin 0.0156-16µg/ml. The results showed that the 
manual Hi-comb strip can be more reproducible, reliable, easy and 
cheaper. The finding of this study urges the use of manual Hi-comb 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
strip in research and hospital in Sudan. This is because Hi-comb is a 
quantitative technique for easily determining the antimicrobial 
susceptibility of Gram-positive and Gram-negative bacteria. 
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Introduction 
             Antimicrobial agents are among the most commonly used and 
misused of all drugs. The inevitable consequence of the widespread use of 
antimicrobial agents has been the emergence of antibiotic-resistant 
pathogens, fueling an ever-increasing need for new drugs. However, the 
pace of antimicrobial drug development has slowed dramatically, with only 
a handful of new agents, few of which are novel, being introduced into 
clinical practice each year. Reducing the inappropriate antibiotic use is 
thought to be the best way to control resistance. Although awareness of the 
consequences of antibiotic misuse is increasing, over prescribing remains 
widespread, driven largely by patient demand, time pressure on clinicians, 
and diagnostic uncertainty. If the gains in the treatment of infectious 
diseases are to be preserved, clinicians must be wiser and more selective in 
the use of antimicrobial agents. The recent emergence of antibiotic 
resistance in bacterial pathogens, both nosocomially and in the community is 
a very serious development that threatens the end of the antibiotic era. 
Today, more than 70% of the bacteria associated with hospital-acquired 
infections in the United States are resistant to one or more of the drugs 
previously used to treat them. Penicillin-resistant strains of pneumococci 
account for 50% or more of isolates in some European countries, and the 
proportion of such strain is rising in the United States. The worldwide 
emergence of Haemophilus and gonococci that produce ß -lactamase is a 
major therapeutic problem. Methicillin-resistant strains of S. aureus are 
endemic in hospitals and are isolated increasingly from community-acquired 
infections (Naimi et al., 2003 and Vandenesch et al., 2003). Multiple-drug-
resistant strains of S. aureus with intermediate susceptibility to antibiotics  
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and high-level resistance to vancomycin have been reported (Hiramatsu et 
al., 1997; Smith et al., 1999 and Weigel et al., 2003). There are strains of 
enterococci, Pseudomonas, and Enterobacter that are resistant to all available 
antibiotics. Epidemics of multiple-drug-resistant strains of Mycobacterium 
tuberculosis have been reported in the United States.  
            The rampant spread of antibiotic resistance mandates a more 
responsible approach to antibiotic use. The Centers for Disease Control and 
Prevention. CDC has outlined a series of steps to prevent or diminish 
antimicrobial resistance. Important components include appropriate use of 
vaccination, judicious use and proper attention to indwelling catheters, early 
involvement of infectious disease experts, choosing antibiotic therapy based 
on local patterns of susceptibilities of organisms, proper antiseptic technique 
to ensure infection rather than contamination, appropriate use of 
prophylactic antibiotics in surgical procedures, infection-control procedures 
to isolate the pathogen, and strict compliance to hand hygiene (Anonymous 
2002a, 2002b). For an antibiotic to be effective, it must reach its target in an 
active form, bind to the target, and interfere with its function. Accordingly, 
bacterial resistance to an antimicrobial agent is attributable to three general 
mechanisms: (1) The drug does not reach its target, (2) the drug is not active, 
or (3) the target is altered (Davies, 1994 and Spratt, 1994; Li and Nikaido, 
2004).The success of treatment of infections depends on the use of 
appropriate antimicrobial agents directed against the pathogen. Many 
hospitals and clinics have facilities for antimicrobial susceptibility testing 
but various constrain a result in the use of an inappropriate antibiotic 
sensitivity, and not determine the minimum inhibitory concentration (MIC) 
of the susceptible antibiotics. MIC has long been the standard for antibiotic 
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susceptibility testing, and it measures the actions of antibiotics against most 
serious organisms and serves as an important reference in the treatment of 
many acute infections and chronic or device-related infections. 
Hi-comb MIC test is based on an innovative antimicrobial gradient 
technique. Various concentrations of antibiotics are impregnated on Hi-
comb filter paper discs of strips. This predefined gradient provides the 
precise and accurate minimum inhibitory concentration in µg/ml antibiotic 
impregnated strip is convenient and can be directly placed on to the surface 
of an inoculated agar plate. On incubation, the resulting zone of inhibition 
appears as an ellipse that intersects the concentration marking, which is 
expressed in terms of MIC of Particular antibiotic. 
Objective: 
· Determination of the minimum inhibitory concentration of ten  
antibiotic against different isolated bacteria in comparison with   the   
reference type cultures. 
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CHAPTER ONE 
                                   1.0 LITERATURE REVIEW 
1.1 General Bacteria isolates used: 
1.1.1 The Genus Escherichia: 
1.1.1.1 Species: 
      The main species of medical importance is Escherichia coli. The genus 
Escherichia belongs to family Enterobacteriaceae (Barrow and Feltham, 
1993). Like many other Enterobacteria contain numerous serotypes some of 
which are associated with certain infections in man and animals. Some are 
particularly associated with diarrhaea disease while other causes a variety of 
extra intestinal infections (Orskov et al., 1976). 
1.1.1.2 General characteristics of Escherichia coli: 
        E. coli is Gram-negative rod shaped, oxidase negative, and catalase 
positive E.coli has a worldwide distribution. Many E.coli is part of the 
normal flora of intestinal tract of human and animals. Some species are free 
living occurring in soil, water and vegetation (Carter, 1986).Many studies 
have been conducted in Sudan concerning E.coli, it was isolated from 
diarrheic calves (Abdelrhman, 2004) from the intestinal tract of animals 
(Osman, 2001) and from different organs of poultry (Abdellah, 2003). 
1.1.1.3 Pathogenciy of Escherichia coli: 
        E. coli causes various diseases in human and animals, including two 
types of infectiondiarrhea (watery diarrhea, cholera like diarrhea), urinary 
tract infection, sepsis, hemorrhagic uremic syndrome and meningitis in man 
(Nastro and kapper, 1998). 
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1.1.1.4 Cultural characteristics: 
        The organism is aerobic and facultative anaerobic in the presence of a 
fermentable carbohydrate. Growth occurred between 14- 45 c° (optimum 
temperature is 37 c°).Optimum PH for growth is 7.00 but growth occurs 
within a wide PH range. It grows readily on ordinary laboratory media. 
Uniform clouding is produced in broth after 12-18-hour incubations. 
Colonies on nutrient agar have slightly raised surfaces. Pigments are not 
produced. Growth on agar slants was confluent with a turbid water of 
syneresis. Wide zones of beta type of haemolysis around colonies are 
produced by some strain. Colonies on agar medium are usually 2-3 mm in 
diameter (Bale et al., 1984). 
1.1.2 Genus: Pseudomonas: 
1.1.2.1 Species: 
       The main species of medical important is Pseudomonas aeruginosa. 
1.1.2.2 General characteristics of Pseudomonas aeruginosa: 
        Pseudomonas aeruginosa is Gram-negative strict aerobe rod, catalase 
positive, oxidase positive (Barrow and Feltham, 1993).It was isolated from 
wound infections in a number of domestic animals and was reported as a 
cause of pneumonia (Abubakr et al., 1980). Furthermore, it was isolated 
from wound infections (Awad elkareen, 2005). 
1.1.2.3 Normal habitat: 
         Pseudomonas aeruginosa is found in water, soil, sewage and 
vegetation. They can be found in intestinal tract of man and animals.  
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Pseudomonas aeruginosa is frequently found in hospital environment 
especially in moist place (Cheesbrough, 1987). 
1.1.2.4 Pathogencity of Pseudomonas aeruginosa: 
        It causes skin infections especially burn sites, wound and ulcers, often 
as secondary invaders. It, Furthermore, causes urinary tract infection usually 
following catheterization and associated with chronic urinary tract infection 
(Cheesbrough, 1987). 
1.1.3 Genus: klebsiella: 
1.1.3.1 Species: 
        The main species of medical importance klebsiella pneumoniae. 
1.1.3.2 General characteristics of Klebsiella pneumoniae:  
        Klebsiella pneumoniae is Gram-negative rod, non-motile, aerobic and 
facultative anaerobes, catalase positive, and oxidase negative (Barrow and 
Felthman, 1993). It was isolated from respiratory tract infection of camel 
(Nasr, 2003), from human ear infection (Osman, 2003), and from wound 
infection (Awad elkareem, 2005). 
1.1.3.3 Normal habitat: 
         Klebsiella pneumoniae could be found in the intestinal tract of human 
and animals, plant, soil and water. K.pneumoniae can be found as common 
commensally organism in mouth, upper respiratory tract and found an in-
hospital environment (Cheesbrough, 1987) (Geo et al., 2001). K.pneumoniae 
is present in the upper respiratory tract, causes a small proportion of 
bacterial pneumonia as an opportunistic pathogen. It may produce pyogenic 
infection of wound, or respiratory tract (Satish, 1995). 
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1.1.4 Genus Staphylococcus: 
1.1.4.1 Species: 
         The main species of medical importance is S. aureus. 
1.1.4.2 General characteristics of Staphylococcus aureus: 
         S. aureus is a Gram-positive spherical cell occurring in single, in pair 
or clusters. They are the natural inhabitants from birth to death. The human 
nose in the natural reservoir of the organism (Briody, 1974). And large 
intestine represented the additional source for the contamination of the 
atmosphere with S.aureus (Buchanan and Gibbon, 1974; Melville and: 
Russel, 1975; Talaro and Talaro, 1993). Staphylococci, particularly 
S.epidermidis, are members of the normal flora of the human skin, 
respiratory and gastrointestinal tracts. (Geo et al., 2001). Many studies had 
been made in Sudan on S.aureus isolation. It was isolated from medical 
laboratories environment (Mohammed, 1997), from eye infections and 
human urine (Mohammed, 2003) and from different sites of human, sheep, 
goats, and poultry (Saeed, 1995). 
1.1.4.3 Pathogencity of Staphylococcus aureus: 
           Staphylococcus aureus usually causes a secondary infection in a 
patient with chronic lung disease (Macsween and Whaley, 1992). S.aureus 
causes boils, pustules, impetigo, infection of wounds ulcers, and burns, 
osteomyelitis, septicemia, and pleumory emphysema (Cheesbrough, 2000). 
1.1.4.4 Treatment to resistance antibiotic: 
           The treatment of choice for S.aureus infection is penicillin; However, 
in most countries, penicillin- resistant is extremely common and first-line 
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therapy is most commonly penicillinase-resistant ß -lactam antibiotic (for e.g. 
oxacillin and flucloxacillin).Combination therapy with gentamicin may be 
used to treat serious infections (Korzeniowski and sande, 1982). 
1.1.5 Genus: Salmonella: 
1.1.5.1 Species: 
         The main species of medical importance are S.typhi, S.paratyphi A, 
S.paratyphi B and S.paratyphi C.  
1.1.5.2 General characteristics of Salmonella: 
      The salmonella is a genus of rod-shaped, Gram-negative, non-spore-
forming, predominantly motile enterobacteria, facultative anaerobes. Most 
species produce hydrogen sulfide. (Clark et al., (1987). The reservoir for 
Salmonella is the intestinal tract (Quinn et al., 2000). Salmonella is wide 
spread in the intestine of birds, reptiles and mammals. It can spread to 
human via a variety of different food of animals origin (CDC, 2003).  
1.1.5.3 Salmonella typhimurium: 
         It is pathogenic Gram-negative bacteria predominately found in the 
intestinal lumen. Its toxicity is due to an outer membrane consisting largely 
of lipopolysaccharide (LPS) which protect the bacteria from the environment 
(Tuin, 2005).It was isolated from diseased birds (Mrden et al.,1987).  
1.1.5.4 Pathogencity of Salmonella typhimurium: 
           Sal.typhimurium causes gastroenteritis in humans and other mammals 
(Everest et al., 1999). Sal. typhimurium is one of the leading causes of 
bacterial food poisoning (Buchwald et al., 2002 and Hardt et al., 1998). 
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1.2 Antibiotics: 
1.2.1 Definition and Characteristics:- 
            Antibiotics are substances produced by various species of 
microorganisms (bacteria, fungi, and actinomycetes) that suppress the 
growth of other microorganisms. Common usage often extends the term 
antibiotics to synthetic include antimicrobial agents, such as sulfonamides 
and quinolones. Antibiotics differ markedly in physical, chemical and 
pharmacological properties, in the antimicrobial spectra, and in mechanisms 
of action (Carpenter and Chambers, 2004). 
1.2.2 Classification and Mechanism of Action:- 
          Based on chemical structure and proposed mechanism of action,   
Antimicrobial agents are classified as follows: 
• Agents which inhibit synthesis of bacterial cell walls.  
• Agents which act directly on the cell, increasing permeability and leading 
to leakage of intracellular compounds (Carpenter and Chambers, 2004). 
• Agents which disrupt the function of 30S or 50S ribosomal subunits to 
reversibly inhibit protein synthesis, which generally are bacteriostatic. 
• Agents which bind to the 30S ribosomal subunit and alter protein 
synthesis, which generally are bactericidal.  
• Agents which affect bacterial nucleic acid metabolism,  
1.2.2.1 Antibiotics that act on cell wall biosynthesis: 
         The bacterial cell wall serves to give the organism its size and shape 
and also to prevent osmotic lysis. The most important antibiotic is divided 
into two groups: ß -lactams and glycopeptides. The ß -lactams were the first 
antibiotics to be discovered and used. the ß -lactams are the most important 
group of drugs that inhibit the final stage of peptidoglycan synthesis (Russell 
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and Chopra, 1990). The penicillins are derived from the fungus penicillium 
and modifications made upon the parent compound can alter the drugs 
spectrum of action. The ß -lactams antibiotics include the penicillin and 
cephalosporin (Walsh, 2003). Cephalosporin consisted of three (Jawetz et 
al., 1989 and cheesbrougt, 2000). Glycopeptides the second class antibiotics 
that have been approved for human use (Moellering, 2006). Vancomycin is 
the most commonly used agent in this class inhibits cell wall synthesis by 
binding to precursors of cell wall synthesis (Forbes et al., 1998).  
1.2.2.2 Antibiotics that inhibits nucleic replication and repair: 
  Replication of nucleic acids of the bacterial cell is prevented directly by 
nalidixic acid and rifamycin. 
1.2.2.2.1 Inhibitors of RNA synthesis and function: 
        These antimicrobials bind to DNA- dependent RNA polymerase and 
inhibit initiation of RNA synthesis e.g. rifamycin, rifampicin and rifaampin 
(Jawetz et al., 1989). 
1.2.2.2.2 Inhibitors of DNA synthesis and function: 
         Quinolones inhabited DNA gyrase (topoisomerase) prevent super 
coiling of DNA (Thomas, 1993). Fluoroquinolones such as ciprofloxacin, 
norfloxacin, and sparfloxacin, it has a broad spectrum of activity  
1.2.2.2.3Antibiotics that act on metabolic pathways: 
        Folate is coenzyme essential for cell growth. However, bacteria cannot 
transport folate and have to synthesis it. Eukaryotes cannot synthesis folate 
and instead scavenge it from dietary sources and transport it into the cell. 
Therefore, selective inhibition achieved. (Greenwood and Whitley, 2003). 
1.2.2.3.1 Sulphonamides: 
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      These antimicrobial are analogues of para-aminobenzoic acid and 
competitively inhibit formation of dihydropteric acid (Todar, 2011).  
1.2.2.4 Antibiotics that inhibit protein synthesis: 
         The most important antibiotics with this mode of action are the 
tetracycline, chloramphenicol, the macrolides and the aminoglycoside. 
1.2.2.4.1 Antibiotics that bind 30s ribosomal subunit: 
        Amino glycosides are a product streptomyces species, Amino glycoside 
bind bound the 30s ribosome and freezes 30s initiation complex  so that no 
further initiation can occur. It is low down protein synthesis that has already 
initiated and induce misreading of the mRNA (Mayer, 2011).  
1.2.2.4.2 Antibiotics that bind 50s ribosomal subunit: 
       Choramphenicol, lincomcin and clindamycin. These antimicrobials bind 
to the 50s ribosome and inhibit peptidyl transferase activity. 
1.2.3 Penicillin and Cephalosporin: 
1.2.3.1 Penicillin: 
      The penicillin constitutes one of the most important groups of. 
antibiotics. Although numerous other antimicrobial agents have  been 
produced since, the first penicillin became available. 
1.2.3.1.1 Chemistry: 
     The basic structure of the penicillin consists of a thiazolidine ring 
connected to a ß -lactam ring to which is attached a side chain the penicillin 
nucleus itself is the chief structural requirement for biological activity.  
 1.2.3.1.2 Semi synthetic Penicillin:  
     The discovery that 6-aminopenicillanic acid could be obtained from 
cultures of P. chrysogenum that were depleted of side-chain precursors led 
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to the development of the semi synthetic penicillin.  . Although knowledge 
of the mechanism of this action is incomplete, numerous researchers have 
supplied information that allows understanding of the basic phenomenon 
(Ghuysen, 1991; Bayles, 2000).  
1.2.3.1.3 Classification of Penicillin:  
      The antimicrobial spectra of penicillin G and penicillin (The 
phenoxymethyl derivative) are very similar for aerobic Gram-positive 
bacteria. Penicillin G has activity against a variety of species of Gram-
positive and Gram-negative cocci (Carratala.,et.al.,1995). 
1.2.3.1.4.The.Aminopenicillins:.Ampicillin.and.Amoxicillin: 
     These agents have similar antibacterial activity and a spectrum    that is 
broad. They all are destroyed by ß - lactamase (from both Gram-positive and 
Gram-negative bacteria). The antimicrobial activity of ampicillin is 
bactericidal.for.both.Gram-positive.and.Gram-negative 
bacteria.(Friedland.and.McCracken,.1994).  
1.2.3.2The.Cephalosporin:  
1.2.3.2.1 Chemistry: 
      Cephalosporin C contains a side chain derived from   D –a -aminoadipic   
acid, which is condensed with a dihydrothiazine ß -lactam ring system  
(7-aminocephalosporanic acid).  
1.2.3.2.2 Mechanism of Action: 
     Cephalosporin and cephamycins inhibit bacterial cell wall synthesis in a 
manner similar to that of penicillin.   
1.2.3.2.3 Classification: 
      The large number of cephalosporin makes a system of classification 
desirable. Although cephalosporin classified by their chemical structure, 
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clinical pharmacology, resistance to ß -lactamase, or antimicrobial spectrum, 
the well-accepted system of classification by "generations" is very useful, 
although admittedly, somewhat arbitrary Classification by generations is 
based on features of antimicrobial activity (Karchmer et al 2000). 
1.2.3.2.3.1 First-Generation Cephalosporin: 
     The first-generation cephalosporin, cephalothin and cefazolin, has good 
activity against Gram-positive and modest.activity.against.Gram-negative.          
1.2.3.2.3.2 Second-Generation Cephalosporin:  
        Second-generation have a broader spectrum than the first-generation 
are active against Enterobacter spp, Proteus spp and Klebsiella spp. 
Cefoxitin is a cephamycin. It is resistant to some ß -lactamases produced by 
Gram-negative rods (Barradell and Bryson, 1994 
1.2.3.2.3.3 Third-Generation Cephalosporin:  
        is highly resistant to many  of the bacterial ß -lactamases and has good 
activity against Gram-positive and Gram- negative (Neu et al.,1979).   
1.2.3.2.3.4 Fourth-Generation Cephalosporin: 
        Cefepime and cefpirome are fourth-generation cephalosporin Cefepime 
has higher activity than ceftazidime and comparable activity to cefotaxime 
for streptococci and methicillin-sensitive S. aureus (Sanders, 1993).  
1.2.4 Macrolides: 
       Use against respiratory infections due to S. pneumonia, S. pyogenes, 
Mycoplasma, legionellaand less serious Staphylococcal infections The 
macrolides inhibit translocation of the peptidyl tRNA by binding to the 50S 
ribosomal 23S RNA (Jawetz et al., 1989). 
1.2.4.1 Erythromycin: 
         Erythromycin is active against most Gram-positive bacteria Neisseria, 
legionella, Staphylococcus and Haemophilus (Todar, 2011). Staphylococci 
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resistant to erythromycin may emerge during a course of erythromycin 
therapy. Culture and sensitivity testing should be performed prior to and 
during therapy. Resistance is generally caused by the dimethylation of a 
specific adenine residue in 23S ribosomal RNA by an enzyme coded by the 
erm A or erm C genes (Skinner et al., 1983 and Weisblum 1995). 
1.2.4.2 Azithromycin: 
          Azithromycin is a 15-membered-ring azalide synthesized from 
erythromycin (Bright et al., 1998 and kirt and sides, 1989).It is effective 
against a wide variety of bacteria such as Hemophilus influenza, 
Streptococcus pneumoniae, Mycoplasma pneumoniae, Staphylococcus 
aureus, Mycobacterium avium and many others. 
1.2.5.Quinolones:  
   The first quinolone, nalidixic acid. It has been available for the treatment 
of urinary tract infections. The introduction of fluorinated 4-quinolones, 
such as ciprofloxacin, moxifloxacin and gatifloxacin represents a important 
therapeutic advance because these agents have broad antimicrobial activity 
and are effective after oral administration for the treatment   of a wide 
variety of infectious diseases. Relatively few side     effects appear to 
accompany the use of these fluoroquinolones, and microbial resistance to 
their action does not develop rapidly (Andriole, 1993;Hooper.2000).  
1.2.5.1 Mechanism of Action: 
      The quinolone antibiotics target bacterial DNA gyrase and 
topoisomerase IV (Drlica and Zhao, 1997). For many Gram-positive 
bacteria (such as S. aureus), topoisomerase IV is the primary activity 
inhibited by the quinolones. In contrast, for many Gram-negative bacteria 
(such as E. coli), DNA gyrase is the primary quinolone target (Hooper, 
2000; Alovero et al., 2000).  
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1.2.5.2 Antibacterial Spectrum:  
         The fluoroquinolones are potent bactericidal agents against E. coli and 
various species of Salmonella, Shigella, Enterobacter, Campylobacter, and 
Neisseria (Eliopoulos and Eliopoulos, 1993) Several intracellular bacteria 
are inhibited by fluoroquinolones at concentrations that can be achieved in 
plasma; these include species of Chlamydia, Mycoplasma, Brucella, and 
Mycobacterium (Leysen et al., 1989; Alangaden and Lerner, 1997). 
Resistance to quinolones may develop during therapy via mutations in the 
bacterial chromosomal genes encoding DNA gyrase or topoisomerase IV or 
by active transport of the drug out of the bacteria (Oethinger et al., 2000).  
 
1.2.6 Antibiotics spectrum:
1.2.6.1 Broad spectrum antibiotics:
           The term broad spectrum is applied to antibacterial agent with 
activity against a wide range of Gram-positive and Gram-negative   bacteria 
such as tetracycline, amino glycosides, Sulphonamides and chloramphenicol 
(Thomas, 1993; Cheebrough, 2000).                                        
1.2.6.2 Narrow spectrum antibiotics: 
         Narrow spectrum antibiotics are those with activity against one or few 
types of bacteria, e.g. vacomycin against Staphylococci and Enterococci 
(Cheesbrough, 2000). 
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1.2.7 Antibiotics resistance: 
      Antibiotics resistance a type of drug resistance where a microorganism is 
able to survive exposure to an antibiotic. While a spontaneous or induced 
genetic mutation in bacteria may confer resistance to antimicrobial drugs, 
genes that confer resistance can be transferred between bacteria in a 
horizontal fashion by conjugation, transduction, or transformation. Thus a 
gene for antibiotic resistance which had evolved via natural selection may be 
shared. Evolutionary stress such as exposure to antibiotics then selects for 
the antibiotic resistant trait. Many antibiotic resistance genes reside on 
plasmids, facilitating their transfer. If a bacterium carries several resistance 
genes, it is called multidrug resistant (MDR) or, informally, a superbug or 
super bacterium. Genes for resistance to antibiotics, like the antibiotics 
themselves, are ancient ( D'Costa ., et al 2011).                                         
 
                                     
1.2.7.1Causes antibiotics resistance: 
      The widespread use of antibiotics both inside and outside of medicine is 
playing a significant role in the emergence of resistant bacteria. (Goossens., 
et al 2005). Although there were low levels of preexisting antibiotic-
resistant bacteria before the widespread use of antibiotics (Caldwell., et al. 
2011). ( Nelson ., et al . 2009).  evolutionary pressure from their use has 
played a role in the development of multidrug resistance varieties and the 
spread of resistance between bacterial species. (Hawkey. et al 2009). Other 
practices contributing towards resistance include the addition of antibiotics 
to livestock feed. (Ferber& Dan2002) (Mathew., et al. 2007).  
 1.2.7.2 Mechanisms:                                                               
 The four main mechanisms by which microorganisms exhibit resistance  
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1. Drug inactivation or modification. 
2. Alteration of target site.  
3. Alteration of metabolic pathway. 
4. Reduced drug accumulation: by decreasing drug permeability or    
increasing active efflux of the drugs across (Li& Nikadio. 2009).  
  How Do Bacteria Become Resistant:

   Bacteria can gain resistance through two primary ways By:            
      1.  Mutation 
2. Using a built-in design feature to swap DNA- bacteria share resistance 
genes.                                                                                                       
An antibiotic kills a bacterial cell by simply disrupting a critical function. 
This is achieved in the cell in much the same way that a saboteur can cause a 
massive jetliner to crash by simply cutting the hydraulic lines.                        
                        
The antibiotic binds to a protein so that the protein cannot function 
properly. The normal protein is usually involved in copying the DNA, 
making proteins, or making the bacterial cell wall—all important functions 
for the bacteria to grow and reproduce.                                                     
If the bacteria have a mutation in the DNA which codes for one of those 
proteins, the antibiotic cannot bind to the altered protein; and the mutant 
bacteria survive. In the presence of antibiotics, the process of natural 
selection will occur, the survival and reproduction of the mutant bacteria.      
                                                                                                 
Although the mutant bacteria can survive well in the hospital environment, 
the change has come at a cost. The altered protein is less efficient in 
performing its normal function, making the bacteria less fit in an 
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environment without antibiotics, the non-mutant bacteria are better able to 
compete for resources and reproduce than the mutant form                        
 (Barnard 2001).                                                                                          
Ciprofloxacin was given to potential victims. cipro bind to a bacterial 
protein called gyrase, decreasing the ability of the bacteria to reproduce. 
This allows the body’s natural immune defenses to overtake the infectious 
bacteria as they are reproducing at a slower rate. Quinolone-resistant 
bacteria have mutations in the genes encoding the gyrase protein. The 
mutant bacteria survive because the Cipro cannot bind to the altered gyras    
This comes at a cost as quinolone-resistant bacteria reproduce more slowly 
(Heddle, 2002).                                                                                             
Resistance to this family of antibiotics is becoming a major problem with 
one type of bacteria which causes food poisoning. This bacteria       
increased its resistance to quinolones 10-fold (Molbak, 2002),                        
                                     
1.2.. Resistant pathogen:  
1. 2...1 Staphylococcus aureusis: 
      One of the major resistant pathogens. It was one of the earlier bacteria in 
which penicillin resistance was found—in 1947, just four years after the 
drug started being mass-produced. Methicillin was then the antibiotic of 
choice, but has since been replaced by oxacillin due to significant kidney 
toxicity. Half of S. aureus infections in the US are resistant to penicillin, 
methicillin, tetracycline and erythromycin.This left vancomycin as the only 
effective agent available at the time. The first documented strain with 
complete resistance to vancomycin, termed vancomycin-resistant 
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Staphylococcus aureus (VRSA) appeared in the United States in 2002(Cirz ., 
et al 2005). However, in 2011 a variant of vancomycin has been tested that 
binds to the lactate variation and also binds well to the original target, thus 
reinstates potent antimicrobial activity. (Chan., et al 2011).  
1.2...2 Pseudomonas aeruginosa 
P. aeruginosa is its low antibiotic susceptibility, which is attributable to a 
concerted action of multidrug efflux pumps with chromosomally encoded 
antibiotic resistance genes and the low permeability of the bacterial cellular 
envelopes. (Albrich, 2004). Besides intrinsic resistance, P. aeruginosa easily 
evolves specific resistance either by mutation in chromosomally-encoded 
genes, or by the horizontal gene transfer of antibiotic resistance 
determinants. Evolution of multidrug resistance by P. aeruginosa isolates 
requires several genetic events that  
include acquisition of different mutations and/or horizontal transfer of 
antibiotic resistance genes. (Hidron. , et al (2008).  
1.2...3 Salmonella and E. coli 
Escherichia coli and Salmonella come directly from contaminated food. 
When both bacteria are spread, serious health conditions arise. Many people 
are hospitalized each year after becoming infected, with some dying as a 
result. By 1993, E. coli resistant to multiple fluoroquinolone variants was 
documented. (Poole, 2004). 
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1.2. Methods of Antimicrobial Susceptibility Testing: 
       Antimicrobial susceptibility testing methods are divided into types 
based on the principle applied in each system. They include:  
1.2..1 Diffusion method:               
The Kirby-Bauer and Stokes' methods are usually used for antimicrobial 
susceptibility testing, with the Kirby-Bauer method being recommended by the 
NCCLS. The accuracy and reproducibility of this test are dependent on 
maintaining a standard set of procedures. 
 1.2.8.2 Dilution method: 
 Dilution susceptibility testing methods are used to determine the minimal 
concentration of antimicrobial to inhibit or kill the microorganism. This can 
be achieved by dilution of antimicrobial in either agar or broth media. 
Antimicrobials are tested in log2 serial dilutions (two fold).    
1.2.8.2.1 Minimum Inhibitory Concentration (MIC):                                 
        Minimum inhibitory concentrations (MICs) are defined as the lowest 
concentration of antimicrobial that will inhibit the visible growth of a 
microorganism after overnight incubation (Jennifer, 2006). MICs are 
considering the glob standard for determining the susceptibility of an 
organism to antimicrobials and are therefore used to judge the performance 
of all other methods of susceptibility testing. MICs are used in diagnostic 
laboratories to confirm unusual resistance, to give a definitive answer when 
a borderline result is obtained by other methods of testing, or                   
when disc diffusion methods are not appropriate, (Jennifer, 2006).                 
                         
There are two methods of testing for MIC:                                               
(a) Broth dilution method                                                                         
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(b) Agar dilution method.                                                                          
1.2.8.3 Diffusion &Dilution method: 
1.2.8.3.1 E-Test: 
      E test which is a quantitative method for antimicrobial susceptibility 
testing applies both the dilution of antibiotic and diffusion of antibiotic into 
the medium. A predefined stable antimicrobial gradient is present on a thin 
inert carrier strip. When this E test strip is applied onto an inoculated agar 
plate, there is an immediate release of the drug. Following incubation, a 
symmetrical inhibition ellipse is produced. The intersection of the inhibitory 
zone edge and the calibrated carrier strip indicates the MIC value over a 
wide concentration range with inherent precision and accuracy. (Lalitha., et 
al 1997). 
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                                                 CHAPTER TWO 
                              2.0 MATERIALS AND METHODS 
2.1 Materials used in the Study: 
1 Disposable gloves 
2 Forceps 
3 70% alcohol for disinfecting 
4 Sterile cotton swabs 
5 Sterile Petri dishes 
6 Aluminum foil 
7 Marker pen 
8 Incubator 
9 Sensitive balance 
10 Bunsen burner 
11 Mueller-Hinton Agar 
12 Antibiotics standard powder 
13 Inoculating loop 
14 Sterile capped test tube 
15 Solvent for the antibiotic(sterile Distilled Water) 
16 Antibiotic standard accompanied by a statement of its activity in µg/ml 
17 Sterile saline(Nacl) 
18 Sterile graduated pipettes of 10ml, 5ml, 2ml and 1ml 
19 Small Screw-capped bottles 
2.2 Aseptic and sterilizations: 
2.2.1 Red heat: 
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     Red heat was used to sterilize loop wires, points and searing spatulas by 
holding them over Bunsen burner flame until became red-hot. 
2.2.2 Hot air oven: 
     It was used to sterilize glass wares such as test tubes, graduated pipettes, 
flasks, Petri dishes, forceps and cotton swabs. The holding period was one 
hour and temperature was 170 C°. 
2.2.3 Moist heat (autoclaving): 
     Autoclaving at 121 C° for 15 minutes was used for sterilization of media 
and plastic wares. 
2.2.4 Disinfection: 
     Phenol disinfectant and 70% ethyl alcohol were used for disinfecting the 
floor and working preparation room in the laboratory. 
2.3 collections of Specimens: 
 2.3.1 Reference strain of bacteria: 
      References bacterial strains were provided by the Central Public Health 
Laboratory.  
Staphylococcus aureus ATCC 25923                       (Gram-positive cocci) 
Escherichia coli ATCC 25922                                (Gram-negative rods) 
Pseudomonas aeruginosa ATCC 27853                  (Gram-negative rods)  
2.3.2 Clinical Isolates: 
     The clinical isolates provided by human and veterinary laboratories 
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Gram-Positive bacteria (Staphylococcus aureus and Staphylococcus 
epidermis). 
Gram-negative bacteria (E. coli, P. aeruginosa, K. pneumonia, Sal. 
typhimurium and Sal.para typhimurium). 
2.4 Quality control: 
        Quality control was performed to check the quality of medium, the  
potency of antibiotic, and check the manual error. Quality control strain  
were included daily with the test to ensure that the method is  
performed correctly. 
2.5 Manual Hi-Comb MIC Test: 
        Hi-comb MIC test is based on an innovative antimicrobial Gradient 
technique. Various concentrations of antibiotics are impregnated on Hi-
comb filter paper discs of strips. This predefined gradient provides precise 
and accurate minimum Inhibitory concentration in µg/ml antibiotic 
impregnated strip is convenient and can be directly placed on to the surface 
of an inoculated agar plate. On incubation, the resulting zone of inhibition 
appears as an ellipse that intersects the concentration marking which is 
expressed in terms of MIC of Particular antibiotic. 
2.5.1 Preparation of Manual Hi-Comb filter paper disc: 
     Hi-Comb consists of a strip, with   14-12 extensions that carry the discs of 
4mm, resembling the´ tooth´ of a comb discs for various concentration of 
antibiotics were impregnated on Hi-comb filter paper discs. The strips were 
placed in a Petri dish and sterilized in a hot air oven in 170 c for 1 hour. 
2.6 Preparation of media and reagent: 
2.6.1 Mueller-Hinton Agar: 
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          Mueller-Hinton agar (Hi media, M173) was prepared according to 
manufacturer instructions. Thirty eight gram of powder was suspended in liter 
of distilled water to PH of 7.2-7.4. Immediately after autoclaving, allow it to 
cool in a 45 to 50C water bath. The freshly prepared agar was poured into 
glass or plastic, flat bottomed Petri dishes on a level table to give a uniform 
depth of approximately 4 mm (this corresponded to 25 -30 ml agar in plate 
with a diameter of 100 mm).The plates were allowed to cool to room 
temperature and, unless the plates were used in the same day, they were stored 
at 2 - 8C in a refrigerator. All Plates used within seven days after preparation. 
A representative sample of each batch of plates was examined for sterility by 
incubating at 37C for 16-18 hours. 
2.6.2 Preparation of McFarland 0.5 turbidity standard: 
      0.5-ml of 0.048 mol/L BaCl2 (1.175% w/v BaCl2. 2H2O) were added to 
99.5ml of 0.18 mol/L (0.36 N) H2SO4 (1% v/v) and mixed thoroughly. The 
tubes were sealed and stored in the dark at room temperature. The standard 
was mixed thoroughly using vortex mixer immediately before use. Standards 
were renewed and their absorbencies were checked after storages for 6 
months. 
2.6.3 Preparation of inoculums: 
      The direct colony suspension method was used to make a suspension of the 
organism in saline to density of McFarland 0.5 turbidity standard 
approximately 1 to 2 ×108 CFU/ml. 
2.7 Preparation of stock solution: 
2.7.1 Standard antibiotic powders: 
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          Ampicillin, amoxicillin, cloxacillin, norfloxacin, ciprofloxacin,  
 
tetracycline, doxycycline, cefaclor, erythromycin, and azithromycin  
antibiotics powders were obtained from General Medicines Company, Ltd  
with potency 85.8%, 86.1, %96%, 89%, 99.7%, 62.2%, 98.9%, 96.1%, 90.9%  
and 105% respectively. 
2.7.2 Preparation of antibiotic solution:    
        Powder was weighed and dissolved in the appropriate diluents distilled 
water to yield the required concentration. The concentration of antibiotics 
solution expressed in µg/ml was based on the potency per disk prescribed by 
WHO and (National Committee for clinical Laboratory Standards.) NCCL of 
United States. The following formula was used in determining the amount of 
antibiotic powder to be used: (1000/P) X V X C=W, where 
 P= potency of the antibiotic base, 
 V=volume in ml required, 
 C=final concentration of solution and 
 W=weight of the antimicrobial to be dissolved in V. 
2.7.3 Preparation of serial dilution:  
     Fourteen to twelve different concentrations were made from the ten 
antibiotics solutions by two- fold dilution method (32, 16, 8, 4, 2, 1, 0.5, 0.25, 
0.125, 0.062, 0.031, 0.0155, 0.0077, 0.0038) µg/ml . Thirty tow µg/ml were 
prepare from the stock of each antibiotic solutions. The first tube in each row 
was from the appropriate stock solution already made. Other tubes containing 
1 ml of diluents. Using sterile pipette 1ml of stock solutions was added from 
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first tube to the second tube, mixed and 1ml was transferred to the next tube 
until the last tube.  
2.7.4 Impregnation of disk: 
       Impregnation Hi-Comb filter paper disc with  the following concentration 
of each antibiotics ( 32, 16, 8, 4, 2, 1, 0.5, 0.25, 0.125, 0.062, 0.031, 0.0155, 
0.0077, 0.0038) µg/ml then the impregnated disk and transfer into sterile Petri 
dishes and labeled with their defined concentration.  
2.7.5 Drying and Storage of Hi-Comb filter paper discs: 
       Without covering the Petri dishes, the disks were allowed to dry in a clean 
incubator at 35C for 2-3 hours. After drying, the disks were placed in small 
sterile air-tight labeled containers with a desiccant at the bottom. A layer of 
sterile cotton or foam was placed over the desiccant to avoid contact with 
disks. The disks were stored in a freezer 1-2 hours before use to equilibrate to 
room temperature before opening to minimize the amount of condensation that 
may occurs when exposed to air. 
2.8 The Procedure: 
          3-5 colonies was isolated of the same morphological were selected from 
agar plate culture.  The top of each colony was touched with a loop, and the 
growth is transferred into a tube containing 4- 5 ml of a sterile saline until it 
achieves the turbidity of the 0.5 McFarland standards, optimally, within 15 
minutes after adjusting the turbidity of the inoculums suspension, a sterile 
cotton swab was dipped into the suspension and the excess fluid was removed 
by turning the swab against the inside of the container. It is important to 
remove excess fluid from the swab to avoid over- inoculums of plates. The 
inoculums were spread evenly over the entire surface of the plate by swabbing 
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in three directions. Impregnated discs were applied by sterile forceps and put 
strip from maximum to minimum concentration. The antibiotic diffused out 
into the agar, producing an exponential gradient of the antibiotics to be tested 
.There was an exponential scale printed on the disks strip. After 16-18 hours of 
incubation, an elliptical zone of inhibition was produced and the point before 
at which the ellipse met the defined disk concentration gave a reading for the 
minimum inhibitory concentration (MIC) of the antibiotics. 
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                                                   CHAPTER THREE 
                                   3. The Results 
        The present study was dealing with seven pathogenic bacterial  
Isolates.(Staphylococcus.aureus,.Staphylococcus.epidermidis, Escherichia 
coli, Pseudomonas aeruginosa, Klebseilla pneumoniae, Salmonella 
typhimurium and Salmonella para typhimurium). Comparison with type 
cultures Staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922 
and Pseudomonas aeruginosa ATCC 27853. All bacteria were tested against 
ten antibiotics via tetracycline, doxycycline, ampicillin, amoxicillin, 
norfloxacin, azithromycin, erythromycin, ciprofloxacin, cloxacillin and  
 Cefaclor(Table 1&2). 
3.1 Sensitivity of the type culture strains to antibiotics: 
3.1.1 Tetracycline: 
     Tetracycline had an inhibitory effect on growth of seven bacterial strains 
examined (Fig 1). At a minimum concentration of 0.032µg/ml the growth of 
S.aureus was inhibited, at 0.125 µg/ml the growth of S.epidmis and 
Sal.paratyphi were inhibited, while at 4µg/ml the growth of Sal.typhi and 
K.pneumoniae were inhibited. However, the growth of E.coli and 
P.aeruginosa it was not inhibited by any concentration (Table, 3). 
3.1.2 Doxycycline: 
       Doxycycline had an inhibitory effect on growth of seven bacterial 
strains examined (Fig 2). At a minimum concentration of 0.0156µg/ml the 
growth of S.aureus was inhibited, at 1 µg/ml the growth of Sal.typhi was 
inhibited, at 0.063 µg/ml the growth of S.epidmis was inhibited, at 8 µg/ml 
the growth of  K.pneumoniae was inhibited while at 0.125µg/ml the growth 
of Sal.paratyphi was inhibited. However, the growth of E.coli and 
P.aeruginosa it is not inhibited by any concentration. (Table, 4). 
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3.1.3 Ampicillin: 
        Ampicillin had an inhibitory effect on growth of the seven bacterial 
strains examined (Fig 3). At a minimum concentration of 0.0156 µg/ml the 
growth of S. aureus was inhibited, at 2 µg/ml the growth of Sal.paratyphi 
and S.epidermis were inhibited, at 1 µg/ml the growth of Sal.typhi was 
inhibited (Fig13) while at 0.5 µg/ml the growth of K.pneumoniae was 
inhibited Fig 20 However, the growth of E.coli and P.aeruginosa it were not 
inhibited by any concentration of ampicillin tested (Table, 5). 
3.1.4 Amoxicillin: 
      Amoxicillin had an inhibitory effect on growth of seven bacterial strains 
examined (Fig 4). At a minimum concentration of 4µg/ml the growth of 
K.pneumoniae was inhibited (Fig17), at 8 µg/ml the growth of S.epidermis 
was inhibited (Fig 21) while at 2µg/ml the growth of S. aureus was inhibited 
(Fig15). However, the growth of E.coli, Sal.typhi, Sal.paratyphi and 
P.aeruginosa were not inhibited by any concentration of amoxicillin tested 
(Fig11&16) (Table, 6). 
3.1.5 Norfloxacin: 
       Norfloxacin had an inhibitory effect on growth of seven bacterial strains 
examined(Fig 5). At a minimum concentration of 0.125µg/ml the growth of 
S.aureus and P.aeruginosa were inhibited, at 0.25µg/ml the growth of 
S.epidermis (Fig18) and Sal.typhi were inhibited(Fig 22), at 0.5µg/ml the 
growth of Sal.paratyphi was inhibited while at 0.032µg/ml the growth of 
K.pneumoniae and E.coli were inhibited. (Table, 7). 
3.1.6 Azithromycin: 
      Azithromycin had an inhibitory effect on growth of seven bacterial 
strains examined. At a minimum concentration of 0.0125µg/ml the growth 
of S.aureus was inhibited, at 1µg/ml the growth of Sal.paratyphi and 
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K.pneumoniae was inhibited, at 0.25µg/ml the growth of Sal.typhi and 
E.coli were inhibited (Fig19), while at 0.5µg/ml the growth of S.epidmisa 
and P.aeruginosa were inhibited. (Fig14)  (Table, 8). 
3.1.7 Erythromycin: 
     Erythromycin had an inhibitory effect on growth of seven bacterial 
strains examined(Fig 7). At a minimum concentration of 0.0156µg/ml the 
growth of S.aureus was inhibited, at 2 µg/ml the growth of Sal.paratyphi and 
S.epidermis were inhibited, at 8µg/ml the growth of E.coli and P.aeruginosa 
were inhibited while at 1µg/ml the growth of K.pneumoniae was inhibited. 
However, the growth of Sal.typhi it is not inhibited by any concentration of 
Erythromycin tested (Table, 9). 
3.1.8 Ciprofloxacin: 
       Ciprofloxacin had an inhibitory effect on growth of all seven bacterial 
strains examined(Fig 8). At a minimum concentration of 0.032µg/ml the 
growth of S.aureus, S.epidermis, P.aeruginosa and Sal.typhi were inhibited, 
at 0.0156µg/ml the growth of K.pneumoniae was inhibited, at 0.063 µg/ml 
the growth of Sal.paratyphi was inhibited while at 0.0078µg/ml the growth 
of E.coli was inhibited(Fig12) (Table, 10).  
 3.1.9 Cloxacillin: 
      Cloxacillin had an inhibitory effect on growth of seven bacterial strains 
examined(Fig 9). At a minimum concentration of 0.063µg/ml the growth of 
S. aureus was inhibited, at 4 µg/ml the growth of E.coli and K.pneumoniae 
were inhibited while at 1µg/ml the growth of S.epidermis was inhibited. 
However, the growth of P.aeruginosa, Sal.typhi and Sal.paratyphi were not 
inhibited by any concentration of cloxacillin tested (Table, 11). 
3.1.10 Cefaclor: 
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     Cefaclor had an inhibitory effect on growth of seven bacterial 
examined(Fig 10). At a minimum concentration of 0.125µg/ml the growth of 
S.aureus was inhibited, at 0.063µg/ml the growth of E.coli and 
K.pneumoniae were inhibited, at 2µg/ml the growth of Sal.paratyphi was 
inhibited while at 0.5µg/ml the growth of Sal.typhi was inhibited. However, 
the growth of S.epidmisa and P.aeruginosa were not inhibited by any 
concentration of Cefaclor tested (Table, 12). 
3.2 Staphylococcus aureus ATCC 25923: 
     In this study the minimum inhibitory concentration of ciprofloxacin, 
norfloxacin, ampicillin, amoxicillin, cloxacillin, tetracycline, doxycycline, 
erythromycin, azithromycin and Cefaclor 0.032, 0.25, 0.0156, 0.032,0.063, 
0.0156, 0.0156, 0.032, 0.032, and 0.063µg/ml respectively to type of strain 
S. aureus ATCC 25923 (Table, 1). 
3.3 Pseudomonas auregnosia ATCC 27853: 
       In this study the minimum inhibitory concentration of ciprofloxacin, 
norfloxacin, erythromycin, azithromycin, and 0.032, 0.125, 0.0078, and 
0.0038µg/ml respectively.However, the antibiotic of ampicillin, 
amoxicillin(Fig11), cloxacillin, doxycycline, and cefaclor were not affected 
by P.auregnosia ATCC 27853 (Table, 1). 
3.4 Escherichia coli ATCC 25922: 
       In this study the minimum inhibitory concentration of ciprofloxacin, 
amoxicillin, cloxacillin, erythromycin, azithromycin, norfloaxcin and 
cefaclor 0.0078, 0. 5, 4, 8, 0.0156 and 0.25µg/ml respectively to type of 
strain E.coli ATCC 25922. However, the antibiotic of ampicillin, 
Tetracycline and doxycycline were not affected by the strain of E.coli ATCC 
25922 (Tabe1). 
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Table (1) Reference strains result in Hi-comb technique 
 
 
Organi
sm 
  Antibiotic MIC µg/ml 
Ciproflox
acin 
Ampici
llin 
Tetracycl
ine 
Cefac
lor 
Amoxic
illin 
Doxycyc
line 
Erythrom
ycin 
Azithrom
ycin 
Cloxaci
llin 
Norflox
acin 
S.aureus 
ATCC 
25923 
0.032 0.0156 0.0156 0.063 0.032 0.0156 0.032 0.032 0.063 0.25 
P.auregn
osia 
ATCC 
27853 
0.032 R 8 R R R 0.0078 0.0038 R 0.125 
Ecoli 
ATCC 
25922 
0.0078 R R 0.125 0.5 R 8 0.25 4 0.0156 
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  Table (2) Result of MIC of antibiotic for various bacteria using Hi-
comb technique 
 
CiprofloxacinAmpicil
lin 
Tetracyclin
e 
Cefaclor Amoxicillin Doxycycline Erythromyci
n 
Azithromy
cin 
Cloxacilli
n 
Norfoxa
cin 
0.0320.0156 0.032 0.125 2 0.0156 0.0156 0.125 0.063 0.125 
0.0322 0.125 R 8 0.063 2 0.5 1 0.25 
0.0078R R 0.063 R R 8 0.25 4 0.032 
0.0321 4 0.5 R 1 R 0.25 R 0.25 
0.0632 0.125 2 R 0.125 2 1 R 0.5 
0.01560.5 4 0.063 4 8 16 1 4 0.032 
0.032R R R R R 8 0.5 R 0.125 
 
Notes: R=Resistanc 
 
 
 Table (3) Distribution frequency of MIC values against Tetracycline 
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  Frequency Percent Valid Percent Cumulative Percent 
Valid R 2 28.6 28.6 28.6 
4.00 2 28.6 28.6 57.1 
.13 2 28.6 28.6 85.7 
.03 1 14.3 14.3 100.0 
Total 7 100.0 100.0  
 
 
      
 
   
Table (4) Distribution frequency of MIC values against Doxycycline 
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  Frequency Percent Valid Percent Cumulative Percent 
Valid R 2 28.6 28.6 28.6 
8.00 1 14.3 14.3 42.9 
1.00 2 28.6 28.6 71.4 
.13 1 14.3 14.3 85.7 
.02 1 14.3 14.3 100.0 
Total 7 100.0 100.0  
 
 
         
 
Table (5) Distribution frequency of MIC values against Ampicillin 
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  Frequency Percent Valid Percent Cumulative Percent 
Valid R 2 28.6 28.6 28.6 
2.00 2 28.6 28.6 57.1 
1.00 1 14.3 14.3 71.4 
.50 1 14.3 14.3 85.7 
.02 1 14.3 14.3 100.0 
Total 7 100.0 100.0  
 
 
 
 Table (6) Distribution frequency of MIC values against Amoxicillin 
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  Frequency Percent Valid Percent Cumulative Percent 
Valid R 4 57.1 57.1 57.1 
8.00 1 14.3 14.3 71.4 
4.00 1 14.3 14.3 85.7 
2.00 1 14.3 14.3 100.0 
Total 7 100.0 100.0  
 
 
 
Table (7) Distribution frequency of MIC values against Norfloxacin 
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  Frequency Percent Valid Percent Cumulative Percent 
Valid .50 1 14.3 14.3 14.3 
.25 2 28.6 28.6 42.9 
.13 2 28.6 28.6 71.4 
.03 2 28.6 28.6 100.0 
Total 7 100.0 100.0  
 
 
 Table (8) Distribution frequency of MIC against Azithromycin 
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  Frequency Percent Valid Percent Cumulative Percent 
Valid 1.00 2 28.6 28.6 28.6 
.50 2 28.6 28.6 57.1 
.25 2 28.6 28.6 85.7 
.13 1 14.3 14.3 100.0 
Total 7 100.0 100.0  
 
 
 
 
 
 
 
 
Table (9) Distribution frequency of MIC against Erythromycin 
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  Frequency Percent Valid Percent Cumulative Percent 
Valid R 1 14.3 14.3 14.3 
8.00 2 28.6 28.6 42.9 
2.00 2 28.6 28.6 71.4 
1.00 1 14.3 14.3 85.7 
.02 1 14.3 14.3 100.0 
Total 7 100.0 100.0  
 
 
 
 Table (10) Distribution frequency of MIC against Ciprofloxacin 
 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
Ͷʹ 
 
 
  Frequency Percent Valid Percent Cumulative Percent 
Valid .06 1 14.3 14.3 14.3 
.03 4 57.1 57.1 71.4 
.02 1 14.3 14.3 85.7 
.01 1 14.3 14.3 100.0 
Total 7 100.0 100.0  
 
 
 
   Table (11) Distribution frequency of MIC values against Cloxacillin 
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  Frequency Percent Valid Percent Cumulative Percent 
Valid R 3 42.9 42.9 42.9 
4.00 2 28.6 28.6 71.4 
1.00 1 14.3 14.3 85.7 
.06 1 14.3 14.3 100.0 
Total 7 100.0 100.0  
 
 
 
 
 
 
       Table (12) Distribution frequency of MIC values against cefaclor 
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  Frequency Percent Valid Percent Cumulative Percent 
Valid R 2 28.6 28.6 28.6 
2.00 1 14.3 14.3 42.9 
.50 1 14.3 14.3 57.1 
.13 1 14.3 14.3 71.4 
.06 2 28.6 28.6 100.0 
Total 7 100.0 100.0  
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Fig (11): Pseudomona  auregnosia ATCC 27853 resistant to amoxicillin 
 
Fig (12): Escherichia coli ATCC 25922 MIC 0.032µg/ml against 
ciprofloxacin 
                                       
Fig (13): Salmonella typhi MIC 1 µg/ml against ampicillin 
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Fig (14): Pseudomonas auregnosia MIC 0.5 µg/ml against azithromycin 
 
Fig (15): Staphylococcus  aureus MIC 2 µg/ml against Amoxicillin 
 
  Fig (16): Salmonella typhi resistant to amoxicillin 
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Fig (17): klebsiella pneumoniae MIC 4 µg/ml against Amoxicillin 
 
 
Fig (18): Staphylococcus epidmis MIC 0. 25 µg/ml against Norfoxacin 
 
 
 
Fig (19): Escherichia coli MIC 0.25 µg/ml against Azithromycin 
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Fig (20): klebsiella pneumonia  MIC 0.5 µg/ml against Ampicillin 
 
Fig (21): Staphylococcus epidmisa MIC 8µg/ml against Amoxicillin 
 
Fig (22): Salmonella typhi MIC 0.25 µg/ml against Norfoxacin 
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CHAPTER FOUR 
               DISCUSSION 
          Previous work has shown that MIC of different antibiotic against 
different clinical Gram- positive and Gram- negative bacterial isolates when 
they were tested by Hi-comb technique.  
       In this study, the minimum inhibitory concentration of ampicillin and 
cloxacillin were 0.0156µg/ml, 0.063µg/ml respectively to S.aureus, while 
P.aeruginosa was resistant to ampicillin and cloxacillin  .This results are 
similar that reported by Issam eldein (2009) who observed that S.aureus was 
sensitive to ampicillin and cloxacillin, while P.aeruginosa was resistant to 
ampicillin and cloxacillin.   
         In this study, the minimum inhibitory concentration of tetracycline     
to S.aureus was 0.032µg/ml, but it was not effective against E.coli.          
This result does not agree with that reported by Nadir (2006) who     
observed that S.aureus was resistant to tetracycline, while                                                    
E.coli did so with a minimum inhibitory concentration of 8µg/ml. 
       The minimum inhibitory concentration of ciprofloxacin, for 
K.pneumoniae was 0.0156µg/ml, while for ampicillin 0.5µg/ml was 
recorded. This result coordinate with  that reported by Elhassan (1999) who 
observed that klebsiella strains were highly variable ranging from high 
sensitivity for  ciprofloxacin to low sensitivity or resistance to ampicillin. So 
that low sensitivity or resistance to ampicillin may be due to the fact that 
most strain of klesiella species is naturally resistance to ampicillin or may be 
due to acquisition of plasmid-encoded resistance (Emmerson et al., 1997). 
However, low sensitivity or resistance to other antibiotics were reported in 
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varying degrees, which may be due to different strategies of prescription of 
antibiotics, misuse of antibiotics or, to a lesser extent, due to different 
biotypes of klebsiella spp. 
In this study, the minimum inhibitory concentration of ampicillin and 
cloxacillin were 0.5µg/ml, 4µg/ml respectively to K.pneumoniae , while  
E.coli was 4 µg/ml to cloxacillin and Sal. Typhimurium was 1 µg/ml to 
ampicillin .This result is does not simulates that reported by Issam eldein 
(2009) who observed that E.coli to be resistant to cloxacillin, while Sal. 
typhimurium to be resistant to ampicillin.   
     The minimum inhibitory concentration of tetracycline, to the 
K.pneumoniae was 4µg/ml, while for doxycycline is 8µg/ml. This result 
simulates that reported by Elhassan (1999) who observed that tetracycline 
was generally moderately effective while doxycycline was generally 
moderate by of low efficacy. 
     The minimum inhibitory concentration of ciprofloxacin, to the E.coli was 
0.0078 µg/ml, while ampicillin, tetracycline, amoxicillin and doxycycline it 
is  not effective against  E.coli .This finding agrees with Ahamed et al., 
(2000) who stated that E.coli showed high rate of resistance to ampicillin, 
amoxicillin and tertracycline  and were completely sensitive to ciprofloxacin 
and also agrees with Forbes et al., (1998) who reported that E.coli  was 
resistant to  one or more of beta- lactam ring antibiotics. This is probably 
due to the fact that Gram- negative bacteria, including entrobacteriaceae and 
other produce dozens of different ß -lactamases enzymes which interfere with 
the action of beta-lactam antibiotics. 
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In this study, the minimum inhibitory concentration of ciprofloxacin, 
erythromycin, azithromycin and norfloxacin to the type strains P. aeruginosa 
was 0.032 µg/ml, 8 µg/ml, 0.5 µg/ml and 0.125 µg/ml respectively, while 
cefacor, amoxicillin, cloxacillin, tetracycline and ampicillin  were  not 
effective against  P.aeruginosa. 
         In this study, P. aeruginosa was resistance to the ampicillin and 
cloxacillin. This result simulates that reported by Issam eldein (2009) who 
observed that ampicillin and cloxacillin were resistance to P. aeruginosa.  
     In the present study P. aeruginosa was resistances to the, ampicillin and 
tetracycline. This result is compassable to that reported by Nadir (2006), 
who observed that P.aeruginosa was resistances to ampicillin and 
tetracycline. In this study, the minimum inhibitory concentration of 
ampicillin to the S.aureus was 0.0156µg/ml, while were not effective against 
E.coli. This result is does not simulate that reported by Nadir (2006) who 
observed that S.aureus was resistant to ampicillin, while E.coli showed a 
minimum inhibitory concentration of 8 µg/ml.   
     The variation of the minimum inhibitory concentration of the antibiotics 
in the present study may be, when compared with the previous similar 
studies, due to the inoculums size, the test techniques itself and vast dilution 
range were used. 
       These results illustrate that ciprofloxacin could be considered the drug 
of choice for treatmentof allbacterial isolatesin this inestigation .The result in 
this study for kelbsiella resemble to Elhassan (1999) who observed the 
ciprofloxacin was the most potent antibiotic and can be recommended for all 
types of Klebsiella infections. 
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Conclusions:- 
From the present study it can be concluded that: 
1 Most strains of Pseudomonas aeruginosa were more  resistant to many 
antimicrobial agents, including beta-lactams, tetracycline,  than most 
other  Gram-negative rods 
2 Tetracycline intrinsically are more active against Gram positive than 
Gram negative bacteria 
3 Ciprofloxacin has excellent activity against the entrobacteriaceace 
4 The high antibiotic resistance showed by P. aeruginosa in the present 
study may be due to the wide misuse of antibiotic in human and 
veterinary medicine. In addition, antibiotics may be continuously used 
in of a nimals foods such as broilers promoter factor. 
5 Ciprofloxacin is more active than norfloxacin against P. aeruginosa  
6 Ciprofloxacin could be considered the drug of choice for treatment 
against bacterial isolates of man and animal. 
Recommendations 
1 Hi-Comb MIC Test  Easy-accurate-fast Convenient and the most 
economical test 
2  Disc of Hi-comb could be prepared locally which will reduce the 
economic cost of the  test 
3 Misuse of antibiotics will lead to the emergence of resistance to these 
antibiotics in future and will end into therapeutic failure. 
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